Rapid Dose Therapeutics Ratios and Metrics

Market cap in millions CAD. Fiscal year is March - February.

Millions CAD. Fiscal year is Mar - Feb.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2018 - 2019
Period Ending	Jun '25 Jun 10, 2025	Feb '24 Feb 29, 2024	Feb '23 Feb 28, 2023	Feb '22 Feb 28, 2022	Feb '21 Feb 28, 2021	Feb '20 Feb 29, 2020	2018 - 2019
Market Capitalization	27	21	9	26	17	27	Upgrade
Market Cap Growth	114.18%	121.17%	-64.76%	56.16%	-36.29%	-57.36%	Upgrade
Enterprise Value	30	23	11	28	18	28	Upgrade
Last Close Price	0.21	0.17	0.09	0.26	0.21	0.34	Upgrade
PS Ratio	16.76	20.20	12.98	15.10	22.43	261.96	Upgrade
PB Ratio	-6.57	-6.53	-3.49	105.16	-15.54	-179.91	Upgrade
P/TBV Ratio	-	-	-	105.16	-	-	Upgrade
EV/Sales Ratio	18.36	23.00	15.75	15.81	24.39	273.86	Upgrade
Debt / Equity Ratio	-0.64	-0.78	-0.79	5.70	-2.01	-9.15	Upgrade
Asset Turnover	0.88	0.49	0.27	0.51	0.19	0.02	Upgrade
Inventory Turnover	2.77	2.79	1.67	1.26	0.43	0.37	Upgrade
Quick Ratio	0.09	0.13	0.04	0.09	0.08	0.03	Upgrade
Current Ratio	0.20	0.23	0.09	0.25	0.19	0.12	Upgrade
Return on Equity (ROE)	-	-	-	-	-	-432.88%	Upgrade
Return on Assets (ROA)	-135.70%	-93.10%	-83.34%	-77.93%	-25.16%	-93.14%	Upgrade
Return on Capital (ROIC)	-	-	-389.55%	-193.25%	-88.74%	-186.44%	Upgrade
Earnings Yield	-21.42%	-20.89%	-40.87%	-32.08%	-10.66%	-29.95%	Upgrade
FCF Yield	-	-11.13%	-9.27%	-11.49%	-9.64%	-16.01%	Upgrade
Buyback Yield / Dilution	-16.59%	-1.50%	-3.19%	-28.83%	-2.23%	-21.26%	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.